Peptonic Medical

The agreements means that Cetro Medical gets an exclusive right to sell VagiVital in the professional channel, i.e. to hospital and clinics. The agreement spans over three years with possible extension.

"In Cetro Medical we get a resourceful partner with a long and successful experience in distribution of products for gynecology and obstetrics. This is a partnership and a cooperation model that we are very much looking forward to develop", says Erik Sundquist, CEO of Peptonic.

It further enables Peptonic to focus on its core business; clinically proven intimate self care according to the principle diagnose, treat, prevent. A user of Peptonics products shall be able to manage everything from identifying and treating the intimate health problem to preventive actions with products that prohibit the problems from returning.

Some of the products are excellent for distribution to different healthcare units;

• VagiVital VS Pro is a customized version of VagiVital VS, which we sell directly to consumers. VagiVital VS Pro enables healthcare professionals to screen for bacterial vaginosis with a unique combination of precision and immediate results.
• VagiVital AL. Allows healthcare professionals to identify amniotic leakage with the same precision as in a gynaecological examination, but without using sterile instruments and need for consulting rooms.

"This is to us an optimization of resources and business potential and a model that we intend to apply when we build our own brand globally in a cost- and resource-efficient way," says Erik Sundquist.

"Cetro Medical delivers innovative and gentle examinations and treatments. We see Peptonic's care-adapted products as perfect additions to our portfolio and are in line with our current offering", says Carlos Wilhemsson, CEO of Cetro Medical.